Cargando…

Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells

Development of endocrine resistance during tumor progression represents a major challenge in the management of estrogen receptor alpha (ERα) positive breast tumors and is an area under intense investigation. Although the underlying mechanisms are still poorly understood, many studies point towards t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Opyrchal, Mateusz, Salisbury, Jeffrey L., Zhang, Shuya, McCubrey, James, Hawse, John, Goetz, Mattew P., Lomberk, Gwen A., Haddad, Tufia, Degnim, Amy, Lange, Carol, Ingle, James N., Galanis, Evanthia, D'Assoro, Antonino B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016211/ https://www.ncbi.nlm.nih.gov/pubmed/24816249 http://dx.doi.org/10.1371/journal.pone.0096995

Ejemplares similares

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells
por: Opyrchal, Mateusz, et al.
Publicado: (2017)

Aurora-A Kinase as a Promising Therapeutic Target in Cancer
por: D’Assoro, Antonino B., et al.
Publicado: (2016)

Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells
por: LEONTOVICH, ALEXEY A., et al.
Publicado: (2013)

Aurora-A overexpression is linked to development of aggressive teratomas derived from human iPS cells
por: Ohmine, Seiga, et al.
Publicado: (2018)

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer
por: Haddad, Tufia C., et al.
Publicado: (2017)

Inhibition of Cdk2 kinase activity selectively targets the CD44(+)/CD24(−/Low) stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells
por: OPYRCHAL, MATEUSZ, et al.
Publicado: (2014)

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
por: Jalalirad, Mohammad, et al.
Publicado: (2021)

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
por: Iankov, Ianko D., et al.
Publicado: (2015)

NOTCH3 expression is linked to breast cancer seeding and distant metastasis
por: Leontovich, Alexey A., et al.
Publicado: (2018)

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
por: Reese, Jordan M, et al.
Publicado: (2014)

Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
por: Zheng, XQ, et al.
Publicado: (2013)

YAP inhibits ERα and ER(+) breast cancer growth by disrupting a TEAD-ERα signaling axis
por: Li, Xu, et al.
Publicado: (2022)

Deciphering of a Putative GPER Recognition Domain in ERα and ERα36
por: Acramel, Alexandre, et al.
Publicado: (2022)

Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer
por: Zheng, Zao-zao, et al.
Publicado: (2022)

Aurora kinase B-phosphorylated HP1α functions in chromosomal instability
por: Williams, Monique M., et al.
Publicado: (2019)

Prevention of Obesity and Insulin Resistance by Estrogens Requires ERα Activation Function-2 (ERαAF-2), Whereas ERαAF-1 Is Dispensable
por: Handgraaf, Sandra, et al.
Publicado: (2013)

Influence of Cellular ERα/ERβ Ratio on the ERα-Agonist Induced Proliferation of Human T47D Breast Cancer Cells
por: Covaleda, Ana M. Sotoca, et al.
Publicado: (2008)

Expression of oestrogen receptors, ERα, ERβ, and ERβ variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERα
por: Collins, Frances, et al.
Publicado: (2009)

Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
por: Li, Yuanyuan, et al.
Publicado: (2013)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Human estrogen receptor-α (ER-α) transactivation by selective estrogen receptor modulators (SERMs) on VIT regulatory region in ER-α-negative breast cancer cell line Evsa-T transiently transfected by ER-α
por: Nyamagana Butera, IP, et al.
Publicado: (2001)

Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
por: Su, Peng, et al.
Publicado: (2014)

Respective role of membrane and nuclear estrogen receptor (ER) α in the mandible of growing mice: Implications for ERα modulation
por: Vinel, Alexia, et al.
Publicado: (2018)

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017)

Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo
por: Visser, Koch, et al.
Publicado: (2013)

ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity
por: Oueslati, Mohamed, et al.
Publicado: (2017)

The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
por: Hojnik, Marko, et al.
Publicado: (2023)

Characterizing the selectivity of ER α-glucosidase inhibitors
por: O’Keefe, Sarah, et al.
Publicado: (2019)

TNFα Enhances Tamoxifen Sensitivity through Dissociation of ERα-p53-NCOR1 Complexes in ERα-Positive Breast Cancer
por: Kim, Hyunhee, et al.
Publicado: (2021)

Progression of Mouse Skin Carcinogenesis Is Associated with Increased Erα Levels and Is Repressed by a Dominant Negative Form of Erα
por: Logotheti, Stella, et al.
Publicado: (2012)

The correlation between DNMT1 and ERα expression and the methylation status of ERα, and its clinical significance in breast cancer
por: ZHANG, WEIJIE, et al.
Publicado: (2016)

Correction: Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo
por: Visser, Koch, et al.
Publicado: (2013)

Differential Roles of ERα and ERβ in Normal and Neoplastic Development in the Mouse Mammary Gland
por: Mehta, Rajendra G., et al.
Publicado: (2014)

Interaction of Coumarin Phytoestrogens with ER(α) and ER(β): A Molecular Dynamics Simulation Study
por: Wang, Ting, et al.
Publicado: (2020)

Functional Significance of Selective Expression of ERα and ERβ in Mammary Gland Organ Culture
por: Mehta, Rajendra G.
Publicado: (2021)

ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions
por: Song, Dandan, et al.
Publicado: (2022)

The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches
por: Jefferi, Nur Erysha Sabrina, et al.
Publicado: (2023)

Estrogen receptor alpha (ERα)–mediated coregulator binding and gene expression discriminates the toxic ERα agonist diethylstilbestrol (DES) from the endogenous ERα agonist 17β-estradiol (E2)
por: Adam, Aziza Hussein Bakheit, et al.
Publicado: (2020)

Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues
por: Poola, Indira, et al.
Publicado: (2007)

From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression
por: Chamard-Jovenin, Clémence, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_duommvakra0rg892urkuupcjm7